Tonix Pharmaceuticals
TNXP
23 hedge funds and large institutions have $11.1M invested in Tonix Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 8 closing their positions.
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
28% more funds holding
Funds holding: 18 → 23 (+5)
0% more ownership
Funds ownership: 0% → 0% (+0%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
57% less capital invested
Capital invested by funds: $25.7M → $11.1M (-$14.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$3.17M |
| 2 |
M
Murchinson
Toronto,
Ontario, Canada
|
+$1.84M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.7M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$590K |
| 5 |
Millennium Management
New York
|
+$517K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.73M |
| 2 |
D.E. Shaw & Co
New York
|
-$1.15M |
| 3 |
State Street
Boston,
Massachusetts
|
-$738K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$369K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$369K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VHAM
76
Van Hulzen Asset Management
El Dorado Hills,
California
| – | -$4K | – | – |
|
77
Victory Capital Management
San Antonio,
Texas
| – | -$10K | – | – |
|
78
VOYA Investment Management
Atlanta,
Georgia
| – | -$29K | – | – |
|
|
WFS
79
Walker Financial Services
Bowling Green,
Kentucky
| – | -$12.9K | – | – |
|
|
X
80
Xponance
Philadelphia,
Pennsylvania
| – | -$5K | – | – |
|
|
ZIG
81
Zuckerman Investment Group
Chicago,
Illinois
| – | -$3K | – | – |
|
TNXP Hedge Fund Activity: Q2 2022 in Review
23 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q2 2022, worth a combined $11.1M — down 57% from $25.7M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new TNXP positions and 8 closed out — a net gain of 5 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $3.17M. The largest seller was BlackRock, cutting an estimated $2.73M.
- 23 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q2 2022, up from 18 in Q1 2022.
- Funds reported $11.1M of Tonix Pharmaceuticals stock for Q2 2022, down 57% quarter-over-quarter.
- 13 funds opened new Tonix Pharmaceuticals positions in Q2 2022 and 8 closed out, a net change of +5 holders.
- The largest Tonix Pharmaceuticals buyer in Q2 2022 was Morgan Stanley, an estimated $3.17M added.
- The largest Tonix Pharmaceuticals seller in Q2 2022 was BlackRock, an estimated $2.73M sold.
Based on aggregated 13F filings for Q2 2022.